EUVIMEDEUVIMED entdecken
Crossref

A rare case of D-penicillamine induced Myasthenia Gravis

Nilima K. Shah, Jinal Parmar, Milind Solanki, Shreyas Patel, Madhav Gojiya

BJKines - National Journal of Basic & Applied Sciences · 08.06.2026 · 18 · 34-36

DOI: 10.25259/bjkines_5_2026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJKines - National Journal of Basic & Applied Sciences, online erschienen am 08.06.2026. Verfasst von Nilima K. Shah und 4 weiteren Autor:innen. Die Arbeit nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

D-Penicillamine (DPA) is a chelating agent widely used for Wilson’s disease, with Myasthenia gravis (MG) reported in approximately 1–7% of treated patients. The proposed mechanism involves immune dysregulation through modification of histocompatibility complex (MHC) molecules, triggering autoimmunity against acetylcholine receptors. DPA–induced MG may occur months to years (6–96 months) after therapy initiation, particularly in Wilson’s Disease patients, and often presents with isolated ocular symptoms with good response to pyridostigmine and clinical remission within one year after DPA treatment cessation.

Zitieren

APA

Shah, N. K., Parmar, J., Solanki, M., Patel, S., & Gojiya, M. (2026). A rare case of D-penicillamine induced Myasthenia Gravis. BJKines - National Journal of Basic & Applied Sciences, 18, 34-36. https://doi.org/10.25259/bjkines_5_2026

Vancouver

Shah NK, Parmar J, Solanki M, Patel S, Gojiya M. A rare case of D-penicillamine induced Myasthenia Gravis. BJKines - National Journal of Basic & Applied Sciences. 2026;18:34-36. doi:10.25259/bjkines_5_2026

BibTeX
@article{Shah2026,
  author = {Shah, Nilima K. and Parmar, Jinal and Solanki, Milind and Patel, Shreyas and Gojiya, Madhav},
  title = {A rare case of D-penicillamine induced Myasthenia Gravis},
  journal = {BJKines - National Journal of Basic & Applied Sciences},
  year = {2026},
  volume = {18},
  pages = {34--36},
  doi = {10.25259/bjkines_5_2026}
}
Kostenlos starten →